Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories
- PMID: 4090993
- DOI: 10.1111/j.1600-0773.1985.tb00052.x
Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories
Abstract
The pharmacokinetics of indomethacin was studied after intravenous and intramuscular injection of 50 mg and administration of rectal solution and suppositories of 100 mg to 8 volunteers. Peak plasma concentrations of indomethacin occurred 20 min. after administration of the rectal solution (3.7 micrograms X ml-1), 40 min. after intramuscular injection (2.7 micrograms X ml-1), and 60 min. after suppositories (3.7 micrograms X ml-1). The bioavailability after the two rectal forms was found to be almost the same, about 80%. After intramuscular injection the bioavailability was calculated to be complete. These results suggest that indomethacin administered as a rectal solution or as intramuscular injection may be an alternative to intravenous administration when an early plasma peak of the drug is required.
Similar articles
-
Pharmacokinetics of indomethacin.Clin Pharmacol Ther. 1975 Sep;18(3):364-73. doi: 10.1002/cpt1975183364. Clin Pharmacol Ther. 1975. PMID: 1100305 Clinical Trial.
-
Absorption and bioavailability of calcium and magnesium salts of indomethacin from rectal suppositories.J Pharmacobiodyn. 1984 Jun;7(6):392-9. doi: 10.1248/bpb1978.7.392. J Pharmacobiodyn. 1984. PMID: 6548261
-
[Pharmacokinetic studies following intravenous, intramuscular and rectal administration of methohexital in children].Anaesthesist. 1984 Jun;33(6):266-71. Anaesthesist. 1984. PMID: 6548095 Clinical Trial. German.
-
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.Arzneimittelforschung. 1998 Sep;48(9):889-99. Arzneimittelforschung. 1998. PMID: 9793614 Clinical Trial.
-
Indomethacin sustained-release?Drug Intell Clin Pharm. 1984 Dec;18(12):1004-7. doi: 10.1177/106002808401801222. Drug Intell Clin Pharm. 1984. PMID: 6391883 Review.
Cited by
-
Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs.Korean J Intern Med. 2020 May;35(3):535-543. doi: 10.3904/kjim.2020.069. Epub 2020 Apr 29. Korean J Intern Med. 2020. PMID: 32392660 Free PMC article. Review.
-
Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.Clin Pharmacokinet. 1991 Aug;21(2):110-28. doi: 10.2165/00003088-199121020-00003. Clin Pharmacokinet. 1991. PMID: 1884566 Review.
-
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.Lancet Gastroenterol Hepatol. 2020 Feb;5(2):132-141. doi: 10.1016/S2468-1253(19)30337-1. Epub 2019 Nov 25. Lancet Gastroenterol Hepatol. 2020. PMID: 31780277 Free PMC article. Clinical Trial.
-
Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Novel Mechanisms and Prevention by Drugs.United European Gastroenterol J. 2025 Feb;13(1):78-85. doi: 10.1002/ueg2.12732. Epub 2024 Dec 23. United European Gastroenterol J. 2025. PMID: 39711464 Free PMC article. Review.
-
Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations.J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):725-741. doi: 10.1007/s10928-021-09768-7. Epub 2021 Jun 17. J Pharmacokinet Pharmacodyn. 2021. PMID: 34142308 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources